NIH #R01AG074010
Dissect the interplay between sex and APOE at the single cell level to uncover novel pathways, targets and therapeutics for Alzheimer's disease
Expiring Soon
- Amount
- $1M–$2M
- Period
- 2021-09-30 → 2026-08-31
- PIs
- 2
Awarded at ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
NIH #R01CA224275
Lipid Unsaturation Drives Ovarian Cancer Progression
Active
- Amount
- $600K–$700K
- Period
- 2018-08-01 → 2031-05-31
- PIs
- 3
Awarded at METHODIST HOSPITAL RESEARCH INSTITUTE
NIH #R01AG095513
Examining Unique Markers and Risk Factors for AD/ADRD in Foreign- and Native-born Older Chinese Americans: A Study of Social Determinants of Health, Sleep Patterns, Neuroimaging, and Plasma Biomarkers
Active
- Amount
- $4M–$5M
- Period
- 2025-09-15 → 2030-08-31
- PIs
- 4
Awarded at ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
NIH #R01NS145483
Structural Studies and Drug Discovery to Interrogate the Function of Neuronal SLC4 Transporters
Active
- Amount
- $600K–$700K
- Period
- 2025-07-01 → 2030-06-30
- PIs
- 3
Awarded at ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
NIH #R01GM163112
Cost-effective workflow for efficient unsaturated lipidomics enabled by a novel ion chemistry
Active
- Amount
- $1M–$2M
- Period
- 2026-04-01 → 2030-03-31
- PIs
- 1
Awarded at UNIVERSITY OF NORTH CAROLINA GREENSBORO
NIH #R01AG085182
Identification and Characterization of Senescent Cells in Molecular Subtypes of Alzheimer's Disease
Active
- Amount
- $800K–$900K
- Period
- 2024-09-15 → 2029-06-30
- PIs
- 2
Awarded at ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
NIH #R35GM133580
Probing and Perturbing Transcriptional Condensates with Multiscale Modeling and Deep Learning
Active
- Amount
- $400K–$500K
- Period
- 2019-08-01 → 2029-05-31
- PIs
- 1
Awarded at MASSACHUSETTS INSTITUTE OF TECHNOLOGY
NIH #R01CA290743
Sustaining antitumor effector CD8+ T cells for cancer therapy
Active
- Amount
- $600K–$700K
- Period
- 2024-05-17 → 2029-04-30
- PIs
- 2
Awarded at NORTHWESTERN UNIVERSITY
NIH #U01AG088351
Age related loss of immune resilience during response to severe respiratory viral infections
Active
- Amount
- $500K–$600K
- Period
- 2024-07-01 → 2029-04-30
- PIs
- 3
Awarded at NEW YORK UNIVERSITY SCHOOL OF MEDICINE
NIH #R01CA290780
Metabolic regulation of immunosuppressive myeloid cells in the tumor microenvironment of pancreatic cancer.
Active
- Amount
- $600K–$700K
- Period
- 2024-04-02 → 2029-03-31
- PIs
- 2
Awarded at UNIVERSITY OF MICHIGAN AT ANN ARBOR
NIH #R01CA286160
Targeting Immune Escape in CML/MPN Transformation
Active
- Amount
- $500K–$600K
- Period
- 2023-12-08 → 2028-11-30
- PIs
- 2
Awarded at BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
NIH #UH3AG083258
Research Infrastructure for the study of Alzheimer's Disease and Alzheimer's Disease-related dementias in older Asian Americans
Active
- Amount
- $1M–$2M
- Period
- 2023-09-15 → 2028-08-31
- PIs
- 4
Awarded at ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
NIH #U01CA299401
Advancing Protein Isoform Analysis through an Integrated Computational Framework.
Active
- Amount
- $300K–$400K
- Period
- 2025-08-01 → 2028-07-31
- PIs
- 2
Awarded at BAYLOR COLLEGE OF MEDICINE
NIH #R01HL169427
Developing hemophilia A therapeutics by targeting translational and posttranslational regulation of FVIII
Active
- Amount
- $500K–$600K
- Period
- 2024-03-15 → 2028-01-31
- PIs
- 1
Awarded at CLEVELAND CLINIC LERNER COM-CWRU
NIH #F99CA305515
From T Cells to Dendritic Cells: Mechanistic Dissection of CTLA4 and TIM3 in Cancer Immunity
Active
- Amount
- <$100K
- Period
- 2025-08-01 → 2027-07-31
- PIs
- 1
Awarded at UNIVERSITY OF CALIFORNIA, SAN DIEGO
NSF #2541725
EAGER: Multimodal AI for Elucidating Genome Structure-Function Relationships in Human Brain Cells
Active
- Amount
- $300K–$400K
- Period
- 2025-08-15 → 2027-07-31
- PIs
- 1
Awarded at Massachusetts Institute of Technology
NIH #U24CA271076
iPGDAC, An Integrative Proteogenomic Data Analysis Center for CPTAC
Active
- Amount
- $800K–$900K
- Period
- 2022-06-01 → 2027-05-31
- PIs
- 1
Awarded at BAYLOR COLLEGE OF MEDICINE
NIH #R01CA258857
Targeting posttranslational modifications of CD73 in TNBCs
Active
- Amount
- $600K–$700K
- Period
- 2021-11-09 → 2027-03-31
- PIs
- 2
Awarded at EMORY UNIVERSITY
NIH #R01CA257926
Innovative Research for Cancer Nanotechnology (IRCN) for Enhancing Melanoma-specific Immune Responses by the Rational Design of Spherical Nucleic Acids
Active
- Amount
- $500K–$600K
- Period
- 2022-03-14 → 2027-02-28
- PIs
- 2
Awarded at NORTHWESTERN UNIVERSITY
NIH #R01CA257520
A deubiquitination module controls Treg adaptation to tumor microenvironment
Active
- Amount
- $500K–$600K
- Period
- 2021-01-01 → 2026-12-31
- PIs
- 2
Awarded at NORTHWESTERN UNIVERSITY
NIH #R01CA258981
The Role of miR-142 in the Transformation of Clonal Hematopoietic Disorders into AML
Active
- Amount
- $500K–$600K
- Period
- 2022-01-01 → 2026-12-31
- PIs
- 2
Awarded at BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
NIH #R01CA250101
The distinct role of cysteinyl leukotriene receptor for myeloid-derived suppressive cells
- Amount
- $500K–$600K
- Period
- 2020-05-15 → 2026-04-30
- PIs
- 1
Awarded at NORTHWESTERN UNIVERSITY
NSF #2042362
CAREER: Chromatin Folding from the Bottom-up
- Amount
- $1M–$2M
- Period
- 2021-02-01 → 2026-01-31
- PIs
- 1
Awarded at Massachusetts Institute of Technology
NSF #1715859
Breaking the Histone Code: Predicting Genome Organization with Chromatin States
- Amount
- $600K–$700K
- Period
- 2017-08-01 → 2020-07-31
- PIs
- 1
Awarded at Massachusetts Institute of Technology
NSF #0970104
RUI: Understanding Quark-Gluon Plasma Properties Via Parton Transport
- Amount
- $100K–$200K
- Period
- 2010-07-15 → 2014-06-30
- PIs
- 1
Awarded at Arkansas State University Main Campus
NSF #0554930
RUI: Dynamical aspects of Quark-Gluon Plasma production
- Amount
- $100K–$200K
- Period
- 2006-07-01 → 2011-06-30
- PIs
- 1
Awarded at Arkansas State University Main Campus
NSF #0140046
Dynamics of ultradense matter produced in relativistic nuclear collisions
- Amount
- <$100K
- Period
- 2002-08-01 → 2006-07-31
- PIs
- 1
Awarded at Arkansas State University Main Campus